Enzymatic Decellularization of Plant Cell Culture Materials
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing tissue engineering scaffolds face challenges such as lack of biocompatibility, use of environmentally unfriendly solvents, and high costs, along with concerns about pathogen transmission and reproducibility, particularly in decellularization processes that damage scaffold structures.
Innovation Solution
A method involving enzymatic decellularization of cellulose-producing cells using DNase to create bioactive scaffolds, where cells are modified to express desired proteins or growth factors, and then decellularized to produce biocompatible scaffolds for tissue engineering and drug delivery applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If mechanical decellularization through freeze thawing is used, then DNA content is reduced, but scaffold structure is damaged
Solution Approach 1:
The patent replaces mechanical decellularization methods (freeze-thawing) with enzymatic decellularization using nucleases. This substitution eliminates mechanical stress on the scaffold while achieving effective DNA removal through biochemical action, thereby preserving scaffold structural integrity while reducing nucleic acid content.
Solution Approach 2:
The patent changes the decellularization mechanism from physical/chemical harsh conditions to controlled enzymatic reaction conditions. By adjusting enzyme concentration, temperature, and pH to optimal ranges for nuclease activity, the process achieves DNA removal without the extreme parameters that damage scaffold structure.
2Quantity of substance
If chemical decellularization utilizing bleaching components is used, then DNA content is reduced, but biocompatibility is compromised
Solution Approach 1:
The patent replaces harsh chemical decellularization methods (bleaching) with enzymatic decellularization using nucleases. This substitution eliminates exposure to toxic chemicals while achieving the same DNA removal goal, thereby maintaining scaffold biocompatibility for tissue engineering applications.
Solution Approach 2:
The patent introduces nucleases as intermediary biological catalysts to mediate the decellularization process. These enzymes specifically target and degrade nucleic acids without affecting other scaffold components, providing a selective and biocompatible decellularization approach compared to non-specific chemical methods.
3Reliability
If mammalian and insect sources are used for scaffolds, then cellular regeneration is supported, but pathogen transmission risk increases
Solution Approach 1:
The patent uses plant cell culture materials as a disposable, renewable source for scaffold production. Plant cells can be rapidly cultured and decellularized to produce scaffolds without the pathogen transmission risks associated with mammalian or insect sources, effectively replacing potentially contaminated biological materials with a safer alternative.
Solution Approach 2:
The patent extracts and utilizes cellulose and other structural components from plant cell walls to create scaffolds. By taking out the useful structural elements from plant cells and removing all cellular contents through decellularization, the process creates biocompatible scaffolds without retaining any pathogen risks from the original plant material.
4Productivity
If conventional scaffold preparation methods are used, then scaffolds can be produced, but production costs are high
Solution Approach 1:
The patent employs plant cell culture materials that are inexpensive to produce at scale compared to mammalian or insect cell sources. These plant-based starting materials can be rapidly grown and processed, significantly reducing the cost of scaffold production while maintaining high productivity through efficient decellularization protocols.
Solution Approach 2:
The patent replaces complex, expensive post-modification steps with a streamlined enzymatic decellularization process. This simplification of the manufacturing workflow reduces both equipment requirements and operational costs, making scaffold production more economically viable while maintaining high output quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in biocompatible scaffolds with retained bioactive molecules, reducing cytotoxic and inflammatory responses, and enabling efficient cell growth and tissue regeneration with improved biocompatibility and cost-effectiveness.
Implementation Method 1
contacting modified plurality of cells with a composition comprising a nuclease, thereby decellularizing the plurality of cells
Data Source
AI summary
Provided herein are enzymatically decellularized cells, and methods of producing said cells, that can be used in a scaffold. The scaffolds featured herein are biocompatible and can comprise decellularized cells that have been modified to express a bioactive agent or molecule.